The Mini+, and all SmartDose portables, feature state-of-the-art technology which allows the unit to continuously monitor the patient and auto-adjust the amount of oxygen delivered as the patient’s needs change, continually matching oxygen dose to exertion level. The Mini+ offers the added benefit of a unique valve system that allows patients to use the device up to 1,000 hours on one set of standard alkaline batteries.
“By integrating a state-of-the-art valving system, we’ve really minimized the amount of time a user has to spend thinking about their oxygen device,” explains Rich Kocinski, CEO of Inspired Technologies. “All SmartDose portables offer auto-adjusting technology to improve patient outcomes; the Mini+ takes it one step further by eliminating the battery hassles of traditional electronic conservers.”
Kocinski continues, “Most clinicians would agree that oxygen conservers don’t work as well as they’d like. Patients try to manually titrate their device to meet increased oxygen needs during ambulation – but they turn it up too late, and then forget to turn it down, wasting oxygen and decreasing the time they’re able to be moving about.”
SmartDose Oxygen Dosing Systems, available in both gas and liquid versions, deliver the ideal balance of saturation and conservation, provide clinicians and HME dealers with vital, patient-specific information, and improve the quality of life for people suffering from COPD.
About Inspired Technologies, Inc. (www.SmarterO2.com)
Inspired Technologies develops respiratory products that help patients live longer, healthier lives. Our oxygen portables, with proprietary SmartDose™ technology, automatically adjust the delivered dose of oxygen in response to the user's breathing patterns, maintaining saturation without wasting oxygen. As the patient's activity level increases, the dose of oxygen is increased, encouraging activity and independence. The unit automatically returns to the original dose as the user's activity level decreases, reducing oxygen waste. We align the goals of patients, clinicians, providers and payers -- all the while focusing on improving patient outcomes and quality of life for those suffering from COPD.
